Xtalks Announces its Life Science Webinar Calendar for April 2026

Upcoming free, educational webinars from Xtalks will feature topics in cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, medical device, pharma manufacturing & supply chain and pharmaceutical regulation.

TORONTO, April 1, 2026 /PRNewswire/ — Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!

Visit www.xtalks.com to see our upcoming webinars:

CELL AND GENE THERAPY

Apr 28 – Accelerating Time to Data in Cell and Gene Therapy Trials

CLINICAL TRIALS

Apr 9 – Improve Recruitment Outcomes Through More Diverse Clinical Trials

Apr 14 – The Glomerular Revolution: Understanding the New Wave of Breakthroughs in Rare Kidney Diseases

Apr 15 – From Integrated Remote SDV to AI-Assisted SDV: What’s Next?

Apr 16 – Respiratory Drug Development: Comprehensive Strategies to Improve Data Quality

Apr 16 – Advancing RBQM Strategy for Greater Impact and Stronger Trials

Apr 21 – Precision Oncology in Practice: Strategies to Drive the Next Generation of Oncology Studies

Apr 22 – Leverage Cognitive Data to Improve Sleep-Wakefulness Drug Evaluation

Apr 23 – Inclusive Research Starts Locally: Improving Trial Readiness Through Community‑Based Models

Apr 28 – How Sleep Biomarkers Improve Clinical Development in Depression Trials

COMMERCIALIZATION & HEOR

Apr 1 – ACA Subsidy Loss: Forecasting Coverage and Revenue Shifts

DRUG DISCOVERY & DEVELOPMENT

Apr 8 – Translational Imaging to Accelerate Cardiovascular Drug Development

Apr 14 – Fast-Tracking IVT mRNA Candidate Selection Through Smarter RNA Design

Apr 15 – Accelerating GLP-1 Peptides to Market Through Integrated Formulation & Analytical Development

Apr 22 – Enhancing Accuracy in E&L with Machine Learning

Apr 24 – Reduce Discovery Risk Using Comorbidity Data, Omics and Knowledge Graphs

Apr 24 – Reduce Protein Structure Bottlenecks in AI-Driven Drug Discovery

Apr 28 – Underneath the Lost Kilos: Muscle Composition, Preservation and Function

Apr 30 – Use Profiling Data to Reduce PROTACs and RIPTACs Program Delays

Apr 30 – Redefining Hematologic Malignancy Drug Development: How Molecular Reclassification, MRD, & AI is Reshaping Precision Hematology

MEDICAL DEVICE

Apr 2 – How to Accelerate Innovation with PCCPs and CI/CD for Medical Devices

PHARMA MANUFACTURING & SUPPLY CHAIN

Apr 21 – De-Risk Supply Disruptions Through Flexible Manufacturing Capacity

PHARMACEUTICAL REGULATION

Apr 27 – Designing Risk-Based QA Oversight for Clinical Trials Under ICH E6 (R3)

ABOUT XTALKS

Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what’s next.

To learn more about Xtalks, visit www.xtalks.com

For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:

Ayesha Rashid

Tel: +1 (416) 977-6555 x272

Email: arashid@xtalks.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/xtalks-announces-its-life-science-webinar-calendar-for-april-2026-302730883.html

SOURCE Xtalks

Disclaimer: The above press release comes to you under an arrangement with PR Newswire. USA Newshour takes no editorial responsibility for the same.

PR Newswire

PR Newswire is a distributor of press releases headquartered in New York City.